Ceesay Abraham's Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Feb 19, 2026
- Accession no.
- 0001193125-26-059886
- Filed
- Feb 19, 2026
- Trade date
- Feb 18, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $320.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ceesay AbrahamCIK 0001722140 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | SSaleDisposed | −3,552 | $29.05 | −$103,185.6 | 558,528 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −2,281 | $29.80 | −$67,973.8 | 556,247 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −2,983 | $29.04 | −$86,626.32 | 22,829 | Indirect | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −2,100 | $29.80 | −$62,580 | 20,729 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.